Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug research, development and life-cycle decisions.
Our Communications
Latest news from Pharmetheus.
May 18, 2022
Population PK analysis supporting accelerated regulatory approvals for tepotinib in metastatic non-small cell lung cancer
May 17, 2022
Introduction to new Board member Birgit Köster Hoffman
May 10, 2022
Welcome Georgina Navia Nilsson!
May 5, 2022
Pharmetheus back from QSPC: highlights
May 3, 2022
Tutorial on a modeling-based alternative to thorough QT (TQT) studies 
April 29, 2022
Introduction to new Board member Magnus Forsbrand
April 27, 2022
Pharmetheus back from WCoP: highlights
April 26, 2022
Welcome Sophie Peigné!
April 19, 2022
Welcome Catalina Barceló!
April 15, 2022
Welcome Anna Mc Laughlin!
May 18, 2022It is our pleasure to introduce Anna Mc Laughlin, Associate Consultant, who recently joined Pharmetheus. Anna’s experience includes pharmacometrics and model-informed precision dosing in oncology and immuno-oncology, especially in cellular therapies, oral anticancer drugs, and targeted drug delivery. Anna is our first employee in Ireland and will be working from Dublin. Welcome Anna!
See Anna's bio here.
Services
Our services include quantitative analyses by scientists with extensive therapeutic area experience industry, academic and regularly settings.
Our team
Request our services
If you are interested in our services, please fill out the form below.
How we work
Our way of working, with traceability and accountability from data programming to report delivery, is well adapted to, and highly compatible with, current regulatory requirements.
Contact
About
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..